Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for MASI:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
March 31, 2026 13.95%
December 31, 2025 15.01%
September 30, 2025 14.45%
June 30, 2025 12.11%
March 31, 2025 12.69%
December 31, 2024 -17.64%
September 30, 2024 7.08%
June 30, 2024 7.21%
March 31, 2024 9.45%
December 31, 2023 6.19%
September 30, 2023 2.21%
June 30, 2023 3.45%
March 31, 2023 3.77%
December 31, 2022 6.63%
September 30, 2022 6.90%
June 30, 2022 3.20%
March 31, 2022 15.32%
December 31, 2021 20.84%
September 30, 2021 18.79%
June 30, 2021 16.46%
March 31, 2021 17.85%
December 31, 2020 23.94%
September 30, 2020 17.76%
June 30, 2020 18.53%
March 31, 2020 23.91%
Date Value
December 31, 2019 21.38%
September 30, 2019 21.43%
June 30, 2019 19.55%
March 31, 2019 21.29%
December 31, 2018 21.03%
September 30, 2018 27.13%
June 30, 2018 20.72%
March 31, 2018 21.43%
December 31, 2017 -3.72%
September 30, 2017 18.54%
June 30, 2017 23.47%
March 31, 2017 26.21%
December 31, 2016
September 30, 2016 16.57%
June 30, 2016 17.39%
March 31, 2016 16.11%
December 31, 2015 14.98%
September 30, 2015 11.87%
June 30, 2015 12.15%
March 31, 2015 12.98%
December 31, 2014 13.47%
September 30, 2014 11.20%
June 30, 2014 9.90%
March 31, 2014 16.09%
December 31, 2013 6.45%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Danaher Corp. 13.89%
Accuray, Inc. -1.92%
ResMed, Inc. 26.20%
Rockwell Medical, Inc. -6.59%
Microbot Medical, Inc. -2.33K%